|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Exploration and evaluation expenditures | |||
| General and administrative expenses | |||
| Equity compensation | |||
| Total expense | |||
| Operating expenses | |||
| Exploration expenditures | |||
| General and administrative expenses (Note 15) | |||
| Total operating expenses | |||
| Other income (expense) | |||
| Transaction costs (Note 16) | |||
| Gain (loss) on financial instruments measured at fair value | |||
| Finance costs | |||
| Finance and other income (expenses) | |||
| Total operating income | |||
| NET LOSS BEFORE DISCONTINUED OPERATION | |||
| Income from discontinued operation | |||
| NET LOSS | |||
| TOTAL COMPREHENSIVE LOSS | |||
| BASIC LOSS PER SHARE FROM CONTINUING OPERATIONS | |||
| DILUTED LOSS PER SHARE FROM CONTINUING OPERATIONS | |||
| BASIC LOSS PER SHARE | |||
| DILUTED LOSS PER SHARE | |||
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED | |||
| Gain on LAC and JV warrant obligations (Note 3) | |||
| Loss on convertible debt and conversion feature (Note 11) | |||
| Gain/(loss) on investments measured at fair value (Note 6) | |||
| Interest expense | |||
| Other income | |||
| Total other expense | |||
| Net loss | |||
| Net income (loss) attributable to: | |||
| Common stockholders | |||
| Non-controlling interest | |||
| Net loss per share attributable to common stockholders, basic (Note 13) | |||
| Net loss per share attributable to common stockholders, diluted (Note 13) | |||
| Weighted average number of common shares outstanding, basic | |||
| Weighted average number of common shares outstanding, diluted |
Loading...